Literature DB >> 8224206

Interleukin-1 beta-induced cytosolic phospholipase A2 activity and protein synthesis is blocked by dexamethasone in rat mesangial cells.

C G Schalkwijk1, M Vervoordeldonk, J Pfeilschifter, H van den Bosch.   

Abstract

Interleukin-1 beta induces gene expression and secretion of the secretory phospholipase A2 (sPLA2) and prostaglandin E2 (PGE2) release from rat mesangial cells. We have previously shown that prolonged treatment of rat mesangial cells with interleukin-1 beta (IL-1 beta) also enhances the cytosolic phospholipase A2 (cPLA2) activity. This effect of IL-1 beta on the cPLA2 activity is inhibited by actinomycin D and cycloheximide, indicating that both transcription and translation are involved. Here, we describe that IL-1 beta increases mRNA levels and protein synthesis of cPLA2 itself. In parallel with the effect of dexamethasone on the sPLA2, this glucocorticoid inhibits the IL-1 beta-enhanced cPLA2 activity as a result of the suppression of IL-1 beta-induced cPLA2 gene expression. This report suggests that the pro-inflammatory action of interleukin-1 beta may, in part, be mediated by its effects on cPLA2 activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224206     DOI: 10.1016/0014-5793(93)80683-l

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.

Authors:  T Miyakawa; M Kojima; M Ui
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

2.  FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism.

Authors:  C Xin; S Ren; W Eberhardt; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

3.  The ω3-polyunsaturated fatty acid derivatives AVX001 and AVX002 directly inhibit cytosolic phospholipase A(2) and suppress PGE(2) formation in mesangial cells.

Authors:  Andrea Huwiler; Astrid J Feuerherm; Benjamin Sakem; Oleksandr Pastukhov; Iuliia Filipenko; Thuy Nguyen; Berit Johansen
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration.

Authors:  C G Schalkwijk; M A van der Heijden; G Bunt; R Maas; L G Tertoolen; P M van Bergen en Henegouwen; A J Verkleij; H van den Bosch; J Boonstra
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

5.  Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE.

Authors:  S Currie; E F Roberts; S M Spaethe; N W Roehm; R M Kramer
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

6.  Dexamethasone down-regulates the 85 kDa phospholipase A2 in mouse macrophages and suppresses its activation.

Authors:  K Gewert; R Sundler
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

Review 7.  Topical glucocorticoids and the skin--mechanisms of action: an update.

Authors:  A Ahluwalia
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.